Cartesian Therapeutics issues options for 121,900 shares to four new employees at $7.22 strike price

• Cartesian Therapeutics granted stock options covering 121,900 shares to four new employees on Oct. 1, 2026.
• Exercise price set at $7.22 per share, matching the Nasdaq closing price on the grant date.
• Options vest 25% on Oct. 1, 2027, then monthly, reaching full vesting on Oct. 1, 2030.
• Ten-year option term.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cartesian Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610020700PRIMZONEFULLFEED9838310) on October 02, 2026, and is solely responsible for the information contained therein.